Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Lasa Supergenerics Ltd (LASA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
24.20 -0.50    -2.02%
10:59:03 - Closed. Currency in INR ( Disclaimer )
  • Volume: 22,148
  • Bid/Ask: 24.20 / 24.30
  • Day's Range: 24.10 - 25.30
Type:  Equity
Market:  India
ISIN:  INE670X01014 
S/N:  LASA
Lasa Supergenerics 24.20 -0.50 -2.02%

Lasa Supergenerics Company Profile

 
Read the Lasa Supergenerics Ltd company profile to learn more about the business and the management team. View Lasa Supergenerics Ltd facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

173

Equity Type

ORD

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use comprising potassium iodide. It also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Contact Information

Address Plot no. C-4 C-4/1
MIDC Lote Parshuram Industrial Area Tal -Khed Ratnagiri, 415722
India
Phone 91 77 9888 8147
Fax -

Top Executives

Name Age Since Title
Omkar Pravin Herlekar 42 2016 Chairman & MD
Hardesh Raja Tolani - 2017 Non-Executive & Independent Director
Ajay Hareshlal Sukhwani 36 2017 Non-Executive Independent Director
Manali Roop Bhagtani - 2018 Non-Executive & Independent Director
Ekta Avtar Gurnasinghani - 2017 Non-Executive & Independent Director
Shivanand Gajanan Hegde 63 2017 Whole Time Director
Umesh Pawar 40 2024 Additional Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LASA Price Commentary

Write your thoughts about Lasa Supergenerics Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ganesh Shekhar
Ganesh Shekhar Aug 23, 2018 7:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Another pump and dump story
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email